Omron Healthcare Expands 'CIIE Circle of Friends' to Advance Collaborative Innovation and Support Healthy China Initiative

ShanghaiNovember 8, 2023PR Newswire -- The 6th China International Import Expo (hereinafter referred to as "CIIE") is being held in full swing at the National Exhibition and Convention Center.November 7Omron Healthcare ("Omron" for short) and Medtronic held a strategic cooperation signing ceremony and the first anniversary celebration of their partnership at the CIIE, focusing on the comprehensive management of hypertension. By jointly establishing a screening and diagnosis system for hypertension, they aim to promote the development of a new ecosystem for hypertension prevention and treatment medical services. In addition, Omron also collaborated with Nikon to host an innovative thematic roundtable forum for the audience centered around the topic of "The Relationship Between Blood Pressure and Eye Health."

Omron and Medtronic Celebrate the First Anniversary of Their Strategic Partnership

Together with Medtronic, Fully Guarding Healthy Heartbeats

At the 5th CIIE, Omron Healthcare and Medtronic reached a strategic cooperation in the field of atrial fibrillation ablation and cardiac rhythm. Over the past year, Omron Healthcare has partnered with Medtronic to connect experts and patients, jointly organizing multiple patient education and free clinics in Suzhou, Wuhan, Guiyang, and Xinjiang. These events provided digital chronic disease management services for users at risk of atrial fibrillation, including rapid experience, data analysis, and risk warning, thereby enhancing patients' awareness of screening and preventing chronic disease complications. The two parties also established a pilot program for atrial fibrillation disease screening and referral pathway construction at hospitals in Jiangsu Province, bringing healthy benefits to potential atrial fibrillation patients.

This year, Omron will continue to deepen its cooperation with Medtronic. At the China International Import Expo (CIIE), a signing ceremony for the strategic cooperation on full-course hypertension management and a celebration marking the first anniversary of the collaboration were held. Mr. Zhao Yao, Director and General Manager of Omron Healthcare (China) Co., Ltd., Mr. Takashi Higashitani, Executive Deputy General Manager of Omron Healthcare (China) Co., Ltd., Mr. Lin Song, Vice President of Cardiac Rhythm, Cardiac Surgery, and Cardiac Ablation Business at Medtronic China, who also serves as the head of the shared functional department for Medtronic’s Cardiovascular Portfolio in China, and Mr. Tao Jia, Vice President of Coronary & Renal Denervation Operations at Medtronic China, attended and witnessed this event.

Omron & Medtronic Strategic Cooperation Signing Ceremony for Comprehensive Hypertension Management Successfully Held, Committed to Safeguarding Healthy Heartbeats

At the signing ceremony, Omron and Medtronic announced an innovative cooperation model in the field of patient education/public education, deepening the construction of a "comprehensive hypertension management" system to help patients with early screening, early prevention, and early diagnosis and treatment. This collaboration aims to raise public awareness and improve the accuracy of early screening, benefiting clinically high-risk patients. Leveraging its strengths in community and pharmacy channels, Omron will integrate Medtronic's product technologies and partner resources in disease diagnosis and treatment to promote interdisciplinary academic exchanges. Together, they will develop client-end supporting solutions, advance the application of new hypertension diagnostic and treatment technologies, implement precision medicine strategies, and build a collaborative ecosystem for blood pressure management for the public.

"Medtronic and Omron Healthcare always adhere to a patient-centered approach, continuously improving product technology and optimizing diagnostic and treatment pathways, enabling patients to access efficient, convenient, and professional health services."Lin Song, Vice President of Medtronic China's Cardiac Rhythm, Cardiac Surgery, and Cardiac Ablation Business Teams, and Head of the Shared Functional Department for Medtronic China's Cardiovascular Business PortfolioSaid: "Looking back at the past year, we are proud of the achievements made in our collaboration in the field of atrial fibrillation ablation and cardiac rhythm; looking ahead, both parties will continue to deepen cooperation and jointly explore broader markets. With the joint efforts of both parties, we hope to bring good news to more patients and help improve the health level of the Chinese people with practical actions."

"At present, two patients have used Omron Healthcare's latest nighttime home blood pressure monitor for post-operative blood pressure monitoring. We can conveniently and clearly observe the post-operative blood pressure changes of patients in Hainan and see the 'Always On' all-day blood pressure control achieved through RDN."'The effect was also seen in the smiles on patients' faces as their blood pressure gradually came under control. "The preliminary exploration results of the cooperation between the two parties mentioned by Mr. Tao Jia, Vice President of Medtronic's Coronary and Renal Denervation Business Operations in China, are encouraging. Renal denervation through radiofrequency ablation, as a novel interventional treatment for hypertension, presents comprehensive management needs before, during, and after the procedure, as well as an opportunity to address patient care, making it the perfect catalyst for collaboration between the two parties.

Partnering with Nikon to Advance Eye Health Diagnostics

Hypertension is a common cardiovascular disease, with a prevalence rate of 5.11% in China, and about 70% of patients show changes in the fundus. As a health management expert for consumers, Omron's MMC Health Convenience and Health Station projects include health experience programs such as fundus lesion early warning, intelligent blood pressure management, and arteriosclerosis early warning, effectively helping individuals at risk of chronic diseases to achieve early prevention, early treatment, and early warning. At this year's CIIE, to further strengthen public awareness of preventing fundus lesions, Omron joined hands with Nikon, a technical expert in the field of fundus testing, to co-host a roundtable forum on the theme of "The Relationship Between Blood Pressure and Fundus Health."

Omron Joins Hands with Nikon to Host a Roundtable Forum on "The Relationship Between Blood Pressure and Eye Health"

Mr. Sun Yanglin, Director of the Academic Department of Omron Healthcare (China) Co., Ltd., Ms. Dong Meiqi, Director of the Brand Strategy Department of Omron Healthcare (China) Co., Ltd., and Mr. Orihara Masaya, Minister of the Optical Machinery Division & Healthcare Business Promotion Department of Nikon Precision Machinery (Shanghai) Co., Ltd., participated in this roundtable forum.

At the forum, representatives and experts from all parties educated the public about the relationship between hypertension and eye health, emphasizing the importance of monitoring eye health and managing chronic diseases. With the MMC Health Convenience Store, patients can easily complete daily early warning tests for fundus lesions and blood pressure management. Through empowering chronic disease management with smart healthcare, Omron is committed to providing consumers with "one-stop chronic disease testing and consultation services at their doorstep."

Nikon Precision (Shanghai) Co., Ltd. Optical Machinery Division&Healthcare Minister of Business Development, Mr. Dongfang Yaya"Managing eye health is an important means of understanding the condition of hypertension. The Omron MMC Health Convenience Store can help users easily and conveniently complete the experience of early warning for fundus lesions. Nikon is honored to conduct this roundtable forum with Omron. Through professional science popularization, we look forward to helping potential patients enhance their awareness of fundus health management, jointly empower the treatment of fundus diseases, and create a better life for people."

Director of Omron Healthcare (China) Co., Ltd.Mr. Zhaoyao Zhao, General Manager"Adhering to the corporate vision of 'Going for ZERO Preventive Healthcare, Making the World Healthier,' Omron is committed to providing chronic disease management solutions for the Chinese market. Leveraging the platform of the CIIE, we actively explore in-depth collaborations with industry partners to build a chronic disease management ecosystem that comprehensively safeguards the health of Chinese consumers. In the future, Omron will continue to work alongside its partners through multi-field and deep-level cooperation, jointly contributing to the realization of 'Healthy China 2030.'"